Analysis Rhythm Pharmaceuticals Inc (RYTM)
5/27/2024
Analysis of Rhythm Pharmaceuticals Inc (RYTM)
Rhythm Pharmaceuticals Inc (RYTM) has been showing some interesting price movements recently. The stock closed at $36.76 on May 24th, after opening at $37.65. The RSI indicator is at 38.89, indicating that the stock is neither overbought nor oversold.Looking at the MACD indicator, we see that it is negative at -0.77329, with the MACD line below the signal line. This suggests a bearish signal for the stock. However, the MACD histogram is showing a slight uptick, indicating a possible reversal in the short term.
In terms of moving averages, the stock is currently below the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) indicators. This indicates a bearish trend in the short term.
Overall, based on the technical indicators, Rhythm Pharmaceuticals Inc may experience some short-term bearish pressure. Traders and investors should closely monitor the MACD histogram for any signs of a trend reversal.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released After Hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.33.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits for a specific company.In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31% and the company's fiscal year ends on September 30, 2023. The income statement reveals an EBITDA of $131.39 billion, revenue of $381.62 billion, and a diluted EPS of 6.44.
Moving on to stock statistics, the company has a short ratio of 1.66, with 94.31 million shares shorted out of 15.31 billion float shares. The stock has a beta of 1.264 and the 52-week range is between $164.08 and $199.62.
Valuation metrics show a PEG ratio of 26.21, forward P/E of 26.21, trailing P/E of 29.43, and a market capitalization of $2.91 trillion. The stock is trading at a price-to-book ratio of 39.18 and a price-to-sales ratio of 7.62.
The stock price summary includes a 50-day moving average of $173.69, a 200-day moving average of $180.79, and a 52-week change of 8.25%.
Lastly, dividends and splits information indicate a payout ratio of 14.93%, with a forward annual dividend rate of $1 and a trailing annual dividend rate of $0.97. The company's dividend yield is 0.53% and the last split date was on August 31, 2020, with a 4-for-1 split.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:- 2020: $274,515,000,000
- 2021: $365,817,000,000
- 2022: $394,328,000,000
- 2023: $383,285,000,000
From these numbers, we can observe that the company has experienced steady revenue growth from 2020 to 2022, with a slight decrease in revenue in 2023. This trend indicates a positive trajectory in the company's top-line performance over the past few years, although a closer analysis of the reasons behind the revenue decrease in 2023 would be necessary to fully understand the situation.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching the highest value in 2023 at $352,755,000,000.
2. Current assets have fluctuated but generally increased over the years, with the highest value in 2023 at $143,566,000,000.
3. Non-current assets have also shown an increasing trend, reaching the highest value in 2023 at $209,017,000,000.
4. Total liabilities have been increasing, with the highest value in 2023 at $290,437,000,000.
5. Shareholders' equity has shown an increasing trend, with the highest value in 2023 at $62,146,000,000.
6. The company has been investing more in non-current assets over the years, indicating potential long-term growth strategies.
7. The company has been managing its debt levels, as seen by the fluctuations in both short-term and long-term debts.
8. Retained earnings have been fluctuating but have generally increased, indicating the company's profitability and reinvestment of earnings.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next two years. The average estimates are showing growth compared to the year-ago EPS figures, indicating optimism among analysts regarding the company's performance.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth rates expected in the next fiscal year.
Growth estimates
Based on the consensus estimates provided:- The company is expected to experience a growth rate of 7.5% in the current year and 9.7% in the next year.
- For the current quarter, the growth rate is estimated to be 5.6%, while for the next quarter it is projected to be 4.8%.
- Over the next 5 years, the company is expected to achieve an average annual growth rate of 11%.
- In the past 5 years, the company has achieved an average annual growth rate of 20.15%.
Overall, the company is expected to maintain a positive growth trajectory, with a slightly lower growth rate in the short term compared to the long-term average.
Price target
Based on the analysts' forecast, the future price of the security is expected to range between $164 (low) and $250 (high), with a median estimate of $200 and an average estimate of $202.26. The current price of the security is $191.57.MACD of RYTM
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
